Mon, June 4, 2012
Sat, June 2, 2012
Fri, June 1, 2012
Thu, May 31, 2012
Wed, May 30, 2012
Tue, May 29, 2012
Mon, May 28, 2012
Sun, May 27, 2012
Sat, May 26, 2012
Fri, May 25, 2012
[ Fri, May 25th 2012 ] - Market Wire
GenVec Reports Inducement Award
Thu, May 24, 2012
Wed, May 23, 2012
[ Wed, May 23rd 2012 ] - Market Wire
Moody's Upgrades Mylan
Tue, May 22, 2012
Mon, May 21, 2012

Isis Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference


//health-fitness.news-articles.net/content/2012/ .. jefferies-2012-global-healthcare-conference.html
Published in Health and Fitness on Tuesday, May 29th 2012 at 4:05 GMT by Market Wire   Print publication without navigation


Isis Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference -- CARLSBAD, Calif., May 29, 2012 /PRNewswire/ --

Isis Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference

[ ]

CARLSBAD, Calif., May 29, 2012 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: [ ISIS ]), the leader in antisense therapeutics, today announced that management will present a company overview at the Jefferies 2012 Global Healthcare Conference on Monday, June 4, 2012 at 2:30 p.m. ET at the Grand Hyatt in New York, NY.

A live audio webcast of the presentation will be available on the "Investors & Media" section of the Company's Web site, [ www.isispharm.com ].  A replay of the presentation will be available on the Isis Web site within 48 hours and will be archived for a limited time.

ABOUT ISIS PHARMACEUTICALS, INC.
Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 25 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer.  Isis' partner, Genzyme, plans to commercialize Isis' lead product, KYNAMRO, following regulatory approval, which is expected in 2012.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at [ www.isispharm.com ].

SOURCE Isis Pharmaceuticals, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.isispharm.com ]


Publication Contributing Sources